How to back a winner this reporting season

stock doctor webinar
Presented by
Kien Trinh

Kien Trinh

Head of Research

Mathew Potts

Mathew Potts

Business Development Manager - Stock Doctor

Feb 23rd, 2021
1h 8m

After a v-shape recovery, the ASX is now back within reach of last year’s market highs. However, all might not be as rosy as it seems, with the February reporting season set to uncover businesses whose Financial Health has been propped up by Government stimulus and capital raisings.

In this webinar recording, Head of Research, Kien Trinh, and Business Development Manager, Mat Potts, explore the risks and opportunities from the reporting season and how you can back winning stocks with Stock Doctor. Australia’s premier DIY share investing platform has helped our members achieve their financial goals with our Star Growth Stocks returning a remarkable 17.9% p.a.* since 1995.

Agenda:

  • The winners and losers from the February reporting season to date
  • The importance of Financial Health as government protection measures wind down
  • The quantitative methodology behind Lincoln’s outperforming Star Stock portfolios
  • Using Stock Doctor to identify growth and income opportunities for the year ahead
  • Q&A

* Performance figure for Star Growth Stocks is from 01/09/1995 – 31/01/2021. This is the average annualised investment performance for each notional portfolio of stocks (based on actual changes in Star Stock recommendations) over the period shown taking into account capital returns, dividend income and estimated transaction costs (but not other distributions, fees, charges or tax) and using various assumptions including assumptions regarding dividend reinvestment and portfolio rebalancing after changes are made to the notional portfolio. These past performance figures are not a reliable indicator of future performance of the notional portfolio, or any stocks included in the portfolio. Investment performance of the notional portfolio over shorter periods will vary. You should not make investment decisions based on performance figures alone. For more detailed information about how these figures are calculated, including the assumptions used, click here.

Presented by
Kien Trinh

Kien Trinh

Head of Research

Mathew Potts

Mathew Potts

Business Development Manager - Stock Doctor

Feb 23rd, 2021
1h 8m
The information in this communication is market commentary only and reflects Lincoln’s views and beliefs at the time of preparation, which are subject to change without notice. To obtain up-to-date information, please contact us.

Important: This communication is provided by or on behalf of Lincoln Indicators Pty Limited ABN 23 006 715 573 (Lincoln), as Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167 for information and educational purposes only. This content may contain general financial product advice. It has been prepared without taking account of your personal circumstances and you should therefore consider its appropriateness in light of your objectives, financial situation and needs, before acting on it. Investments can go up and down. Past performance is not a reliable indicator of future performance. Shares and other investments may go up and down in value, and their past performance may not be repeated and gives no guarantee of future performance. Information in this communication was current as at the date of its preparation, unless otherwise stated, and may be subject to change.

You should read and consider our Important Information and our Financial Services Guide (FSG) which sets out key information about the services we provide. Where our advice relates to the acquisition or possible acquisition of a particular financial product, you should obtain a copy of and consider the Product Disclosure Statement (PDS) for the product at www.lincolnindicators.com.au before making any decision.

At the date of preparation of this communication, Lincoln, Lincoln Financial Group Pty Ltd or directors, employees and/or associates of these entities "may hold" interests in these ASX-listed companies. Further information about particular stocks held by these entities or persons from time to time is disclosed within the Stock Doctor program and may change at any time without notice.

Lincoln, Lincoln Financial Group Pty Ltd, any directors, employees and agents of these entities, make no representation and give no warranty as to the accuracy of this communication and do not accept any responsibility for any errors or inaccuracies in, or omissions from, this communication (whether negligent or otherwise) and are not liable for any loss or damage howsoever arising as a result of any person acting, or refraining from acting, in reliance on any information in this communication. No person should rely on this communication as it does not purport to be comprehensive. This disclaimer does not purport to exclude any rights under, or warranties implied by, law which may not be lawfully excluded.

Lincoln has taken precautions to minimise the risk of transmitting software viruses, but we advise you to carry out your own virus checks on any downloadable content. We do not accept liability for any loss or damage caused by software viruses.

Copyright © 2021 Lincoln Indicators Pty Ltd. All rights reserved.

All financial services are provided by Lincoln Indicators Pty Ltd ABN 23 006 715 573 (Lincoln) as the Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167.